Datasheet | April 5, 2022

Gene Therapy Ready Site Network

Source: Advarra
Scientist lab cell and gene dna GettyImages-1305079941

Join more than 1,000 research sites who use Advarra as their IBC of record. Advarra complies with NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and can provide support for research and clinical trials involving:

  • Recombinant DNA
  • Synthetic nucleic acid molecules
  • mRNA engineered vaccines
  • Genetic engineering/gene therapy
  • Infectious microorganisms
  • Hazardous biological materials
  • Non-clinical plant and animal research

To learn more about Advarra, visit their Clinical Leader page.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader